Medical Diagnostic Laboratories’ approach blends DNA-based molecular testing with traditional pathology and cytology tests to aid in diagnosing or screening for urologic conditions.
miR Scientific's urine-based, noninvasive cancer test can detect molecular evidence of prostate cancer with sensitivity of 94% and specificity of 92%.
Study data demonstrate the ability of the Adapt system to differentiate exosomes from cancer cell subtypes from the same tumor type.
The FFPE Tissue Dissociation kit from Miltenyi Biotec offers a standardized protocol for the dissociation of carcinoma samples prior to the enrichment of carcinoma tumor cells for molecular analysis.
Read More
Unmatched resources will enable researchers to identify distinctive disease mechanisms in small patient subgroups, supporting the development of custom therapeutic approaches.
Read More
The Navify guidelines app pulls the latest clinical guidance for breast, colorectal, non-small cell lung, and prostate cancers from the National Comprehensive Cancer Network.
Read More
The POC test would immediately help prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins.
Read MoreSome women may benefit from risk assessment, counseling, and testing for rare genetic mutations, says USPSTF.
Read MoreTrial results confirm the potential benefits of using biomarkers to guide care for men with metastatic castration-resistant prostate cancer.
Read More
The study’s objective was to evaluate the ability of the Prolaris test and the Prolaris test combined with clinical information to predict a patient’s 10-year risk of progression to metastatic disease.
Read More
Monitoring cancer therapy in real time enables physicians to make smarter treatment decisions.
Read MoreThe test is designed to deliver a simple, fast, and easy way for healthcare professionals and consumers to read test results.
Read More
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Read More
In a field where highly trained professionals interact on a daily basis with an ever-changing array of innovative technologies, new and useful ideas seem to be around every corner.
Read More
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
The test helps clinicians to determine whether a patient with metastatic castration-resistant prostate cancer will benefit most from taxane chemotherapy or androgen-directed therapeutics.
Read More
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read More
Innovative workflow enables isolation of pure tumor cells for precise genomic analysis.
Read More